The results are spectacular, but it is far too early to claim victory. According to an American study not yet published in a scientific journal, taking ivermectin - a parasitic treatment - in patients hospitalized for a Covid-19 is associated with a significant reduction in mortality, and a shorter length of stay. "Although we report a strong potential benefit against Covid-19, these results should not be considered conclusive" at this stage, warn the authors who justify the public availability of these preliminary data by the urgency of the health crisis.
Read also: Treatment against Covid-19: ways to contain the progress of the virus in the body
Scientists, renowned researchers from the American universities of Utah and Harvard, conducted a retrospective observational study. They reviewed the files of patients diagnosed with Covid-19 and searched for those who had received ivermectin in order to compare them with others who had not received ivermectin. Over 1400
This article is for subscribers only. You have 76% left to discover.
Subscribe: € 1 the first month
cancellable at any time
Enter your emailAlready subscribed? Log in
